Provides one-year bridge funding for highly rated but unfunded NIH R01-level cystic fibrosis research to help generate data for competitive resubmission.
Funder: Cystic Fibrosis Foundation
Due Dates: November 30, 2026 (full application; rolling submissions accepted until 5:00 PM ET)
Funding Amounts: Up to $125,000 (direct costs only) for one year; indirect costs not allowed.
Summary: Provides bridge funding for highly rated but unfunded cystic fibrosis research projects previously submitted to NIH or equivalent agencies.
Key Information: Only R01 or equivalent applications with an impact score of 1–45 within the past 12 months are eligible; one-year funding limit.
This program supports outstanding cystic fibrosis (CF) research projects that have been reviewed by the NIH (or an equivalent governmental funding agency) as R01 applications and received an impact score of 1–45 but were not funded due to budget constraints. The goal is to maintain momentum in promising CF research by providing short-term bridge funding to generate preliminary data, thereby strengthening the competitiveness of resubmitted applications for future governmental support. The award is not intended to replace governmental funding, but rather to ensure that highly meritorious CF research projects continue moving forward.